US equities |
INTC $63.65 ▼-30.87% AMZN $238.16 ▼-2.31% NVDA $201.94 ▼-5.49% MU $865.20 ▼-7.39% SNDK $1,124.37 ▼-15.46% GOOGL $277.84 ▼-2.11% AMD $497.16 ▼-12.23% SPCX $135.94 ▼-5.53%
FinancialContent

InMode Ltd. - Ordinary Shares (NQ:INMD)

13.26 -0.25 (-1.85%)
Delayed Quote Updated: 2:17 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InMode Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
InMode (NASDAQ:INMD) Q2 Revenue Inline, EPS Beats; Shares Dip 2.5% ↗
Via Chartmill
News headline image
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One
Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU) 
From American News Group
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into InMode Ltd. (INMD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
InMode (NASDAQ:INMD) Slumps After Q1 2026 Earnings Miss Overshadows Revenue Beat ↗
Via Chartmill
Topics Earnings
InMode Ltd. (NASDAQ:INMD) Reports Q4 2025 Earnings Beat Amid Revenue Shortfall ↗
Via Chartmill
Topics Earnings
InMode Ltd (NASDAQ:INMD) Passes Key Peter Lynch GARP Investment Filters ↗
Via Chartmill
INMD Stock Draws Investor Attention On Q4 Financial Update ↗
Via Stocktwits
InMode Ltd. (NASDAQ:INMD): A Peter Lynch-Style GARP Investment Candidate ↗
Via Chartmill
News headline image
InMode Ltd. (INMD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into InMode Ltd. (INMD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
From Biotech Insider
Via GlobeNewswire
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Earnings Scheduled For November 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For July 30, 2025 ↗
 
Via Benzinga
News headline image
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
Issued on behalf of Conexeu Sciences Inc. 
From Biotech Insider
Via GlobeNewswire
News headline image
InMode (INMD) Q1 2026 Earnings Call Transcript ↗
InMode (INMD) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
InMode (INMD) Stock Slips As Board Ends Review ↗
Shares of InMode Ltd (NASDAQ: INMD) are trading lower Monday morning after the Israeli medical technology company said a special independent transaction committee has ended its strategic review without... 
Via Benzinga
News headline image
InMode (INMD) Q4 2025 Earnings Call Transcript ↗
InMode (INMD) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
InMode Shares Are Rallying After Hours – What’s The Takeover Offer? ↗
Steel Partners said it is pursuing an acquisition of 51% of InMode’s outstanding shares. 
Via Stocktwits
News headline image
INMD Stock Jumped Nearly 13% Today – What’s Powering The Rally? ↗
According to a Calcalist report, the company is set to go private after a $1.1 billion acquisition by a fund. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
InMode Ltd. (NASDAQ:INMD) Emerges as a Peter Lynch-Style GARP Candidate ↗
InMode stock aligns with Peter Lynch's GARP strategy, showing strong earnings growth, high profitability, zero debt, and an undervalued PEG ratio for long-term investors. 
Via Chartmill
News headline image
InMode Ltd (NASDAQ:INMD): A Peter Lynch-Style GARP Investment Candidate ↗
InMode Ltd fits Peter Lynch's GARP strategy with strong earnings, zero debt, and a low PEG ratio, making it a compelling long-term investment candidate. 
Via Chartmill
News headline image
InMode (INMD) Q3 2025 Earnings Call Transcript ↗
InMode (INMD) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings World Trade
News headline image
InMode Ltd (NASDAQ:INMD) Tops Q3 2025 Earnings and Revenue Estimates ↗
InMode Q3 2025 earnings beat estimates on revenue and EPS, showcasing strong profitability and demand for its medical aesthetic products. 
Via Chartmill
Topics Earnings
News headline image
INMODE LTD (NASDAQ:INMD) Appears to Fit Peter Lynch's Investment Criteria ↗
InMode (INMD) aligns with Peter Lynch's GARP strategy, showing strong earnings growth, zero debt, and a low PEG ratio for long-term value. 
Via Chartmill
News headline image
INMODE LTD (NASDAQ:INMD): A Peter Lynch-Style GARP Investment ↗
INMODE LTD (INMD) aligns with Peter Lynch's GARP strategy, showing strong earnings growth, zero debt, and an undervalued PEG ratio for long-term investors. 
Via Chartmill
News headline image
InMode Ltd. (NASDAQ:INMD) Embodies Peter Lynch's GARP Strategy with Strong Financials and Undervalued Growth ↗
InMode (INMD) is a debt-free medical aesthetics stock with strong profitability and a low P/E ratio, fitting Peter Lynch's GARP strategy for growth at a reasonable price. 
Via Chartmill
News headline image
InMode Ltd (NASDAQ:INMD) Embodies Peter Lynch's GARP Philosophy with Strong Growth and Undervalued Metrics ↗
Discover InMode (INMD), a top GARP stock per Peter Lynch's strategy. Strong earnings growth, zero debt, and a low PEG ratio highlight its value in the medical aesthetics sector. 
Via Chartmill
News headline image
INMODE LTD (NASDAQ:INMD): A Peter Lynch-Style GARP Investment with Strong Fundamentals and Undervalued Growth Potential ↗
Peter Lynch’s GARP strategy highlights INMODE LTD (INMD) as a strong candidate with steady earnings, low debt, and undervalued growth potential. 
Via Chartmill
News headline image
InMode Ltd (NASDAQ:INMD) Reports Mixed Q2 2025 Results: Revenue Miss but EPS Beat Drives Pre-Market Gains ↗
InMode's Q2 2025 earnings show mixed results: revenue missed estimates at $95.6M, but EPS beat at $0.47. Shares rose 3.4% pre-market on strong profitability. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >